1. Home
  2. FLOC vs RAPT Comparison

FLOC vs RAPT Comparison

Compare FLOC & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLOC
  • RAPT
  • Stock Information
  • Founded
  • FLOC 1996
  • RAPT 2015
  • Country
  • FLOC United States
  • RAPT United States
  • Employees
  • FLOC N/A
  • RAPT N/A
  • Industry
  • FLOC Metal Fabrications
  • RAPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLOC Industrials
  • RAPT Health Care
  • Exchange
  • FLOC Nasdaq
  • RAPT Nasdaq
  • Market Cap
  • FLOC 417.7M
  • RAPT 498.4M
  • IPO Year
  • FLOC 2025
  • RAPT 2019
  • Fundamental
  • Price
  • FLOC $15.88
  • RAPT $29.03
  • Analyst Decision
  • FLOC Strong Buy
  • RAPT Strong Buy
  • Analyst Count
  • FLOC 6
  • RAPT 8
  • Target Price
  • FLOC $30.17
  • RAPT $46.75
  • AVG Volume (30 Days)
  • FLOC 394.6K
  • RAPT 700.3K
  • Earning Date
  • FLOC 11-05-2025
  • RAPT 11-11-2025
  • Dividend Yield
  • FLOC 2.03%
  • RAPT N/A
  • EPS Growth
  • FLOC N/A
  • RAPT N/A
  • EPS
  • FLOC 3.01
  • RAPT N/A
  • Revenue
  • FLOC $760,923,000.00
  • RAPT N/A
  • Revenue This Year
  • FLOC $47.57
  • RAPT N/A
  • Revenue Next Year
  • FLOC $8.16
  • RAPT N/A
  • P/E Ratio
  • FLOC $5.23
  • RAPT N/A
  • Revenue Growth
  • FLOC 155.05
  • RAPT N/A
  • 52 Week Low
  • FLOC $14.03
  • RAPT $5.67
  • 52 Week High
  • FLOC $30.50
  • RAPT $42.39
  • Technical
  • Relative Strength Index (RSI)
  • FLOC 55.88
  • RAPT 58.56
  • Support Level
  • FLOC $14.06
  • RAPT $29.00
  • Resistance Level
  • FLOC $15.29
  • RAPT $42.39
  • Average True Range (ATR)
  • FLOC 0.63
  • RAPT 3.59
  • MACD
  • FLOC 0.17
  • RAPT -0.40
  • Stochastic Oscillator
  • FLOC 84.67
  • RAPT 25.88

About FLOC Flowco Holdings Inc. Class A Common Stock

Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Share on Social Networks: